These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6694976)
1. Bromocriptine inhibits growth hormone release from rat pituitary cells in primary culture. Cronin MJ; Thorner MO; Hellmann P; Rogol AD Proc Soc Exp Biol Med; 1984 Feb; 175(2):191-5. PubMed ID: 6694976 [TBL] [Abstract][Full Text] [Related]
2. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin. Cronin MJ; Thorner MO J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209 [TBL] [Abstract][Full Text] [Related]
3. One minute of bromocriptine irreversibly inhibits prolactin release for hours. Cronin MJ; Evans WS; Thorner MO Eur J Pharmacol; 1984 Mar; 99(1):85-90. PubMed ID: 6723793 [TBL] [Abstract][Full Text] [Related]
4. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion. Lamberts SW; Verleun T; Zuiderwijk JM; Oosterom R Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995 [TBL] [Abstract][Full Text] [Related]
5. Effects of culture age on PRL and GH responses to bromocriptine and somatostatin from primary cultures of rat anterior pituitary cells. Hanew K; Rennels EG Proc Soc Exp Biol Med; 1982 Oct; 171(1):12-8. PubMed ID: 6128737 [No Abstract] [Full Text] [Related]
6. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone. Cronin MJ; Perkins SN; Keefer DA; MacLeod RM Mol Cell Endocrinol; 1982 Oct; 28(2):229-46. PubMed ID: 7128925 [TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of the diethylstilbestrol-induced proliferation of the anterior pituitary gland of the Fisher 344 rat. Miyazaki K; Dambrosia JM; Kebabian JW Neuroendocrinology; 1985 Nov; 41(5):405-8. PubMed ID: 2932654 [TBL] [Abstract][Full Text] [Related]
8. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491 [TBL] [Abstract][Full Text] [Related]
10. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape. Arita J; Hashi A; Hoshi K; Mazawa S; Suzuki S Neuroendocrinology; 1998 Sep; 68(3):163-71. PubMed ID: 9734000 [TBL] [Abstract][Full Text] [Related]
11. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells. Johansen PW; Haug E; Gautvik KM Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970 [TBL] [Abstract][Full Text] [Related]
12. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells. Login IS; Trugman JM Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of bromocriptine and somatostatin on growth hormone gene expression in the rat anterior pituitary gland in vitro. Wood DF; Docherty K; Ramsden DB; Sheppard MC Mol Cell Endocrinol; 1987 Aug; 52(3):257-61. PubMed ID: 2888694 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor. West B; Dannies PS Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory patterns by CB 154 of prolactin and growth hormone responses to partially purified bovine hypothalamic extracts (39879). Kokubu T; Sawano S Proc Soc Exp Biol Med; 1977 Oct; 156(1):78-81. PubMed ID: 909897 [No Abstract] [Full Text] [Related]
16. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Oomizu S; Boyadjieva N; Sarkar DK Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819 [TBL] [Abstract][Full Text] [Related]
17. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary. Pisarek H; Stepien H; Pawlikowski M Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203 [TBL] [Abstract][Full Text] [Related]
18. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells. Valerio A; Alberici A; Tinti C; Spano P; Memo M J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260 [TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of dopamine and bromocriptine on induced prolactin release: multiple sites for the inhibition of dopamine. Hanna S; Shin SH Neuroendocrinology; 1992 May; 55(5):591-9. PubMed ID: 1316563 [TBL] [Abstract][Full Text] [Related]